Does RAMUCIRUMAB Cause Agranulocytosis? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Agranulocytosis have been filed in association with RAMUCIRUMAB (CYRAMZA). This represents 0.3% of all adverse event reports for RAMUCIRUMAB.
17
Reports of Agranulocytosis with RAMUCIRUMAB
0.3%
of all RAMUCIRUMAB reports
3
Deaths
11
Hospitalizations
How Dangerous Is Agranulocytosis From RAMUCIRUMAB?
Of the 17 reports, 3 (17.6%) resulted in death, 11 (64.7%) required hospitalization, and 2 (11.8%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAMUCIRUMAB. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does RAMUCIRUMAB Cause?
Malignant neoplasm progression (743)
Death (492)
Interstitial lung disease (269)
Febrile neutropenia (229)
Neutropenia (229)
Decreased appetite (187)
Diarrhoea (186)
Hypertension (175)
Pyrexia (161)
Nausea (160)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which RAMUCIRUMAB Alternatives Have Lower Agranulocytosis Risk?
RAMUCIRUMAB vs RANEXA
RAMUCIRUMAB vs RANIBIZUMAB
RAMUCIRUMAB vs RANIMUSTINE
RAMUCIRUMAB vs RANITIDINE
RAMUCIRUMAB vs RANITIDINE\RANITIDINE